CAPTRUST Financial Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25
Closed -$5K 3385
2022
Q2
$5K Buy
25
+20
+400% +$8.6K ﹤0.01% 4102
2022
Q1
$3K Buy
5
+1
+25% +$602 ﹤0.01% 4373
2021
Q4
$3K Buy
4
+3
+300% +$2.22K ﹤0.01% 4295
2021
Q3
$1K Hold
1
﹤0.01% 4462
2021
Q2
$1K Buy
+1
New +$764 ﹤0.01% 4364

Other funds holding OM

CAPTRUST Financial Advisors's OM Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Outset Medical (OM) in Q3 2022, closing a stake of 25 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in OM in Q2 2021 and held it in 5 quarters. The position peaked at $5K in Q2 2022. 138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Outset Medical position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 25 Outset Medical shares in Q3 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Outset Medical in Q2 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Outset Medical position peaked at $5K in Q2 2022.
  • 138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.